Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Link?
Quick Answer; Viable
Read it. Garbage. I wouldn't risk a plug nickel based on it
LOL,sooooo a selectively edited quote from knowledgeable individual was valuable support for a fuel sale, but all the REST of the same individual's quotes, revealing the classic face plant nature of the entire transaction are suspect ?
LOL,sooooo a selectively edited quote from knowledgeable individual was valuable support for a fuel sale, but all the REST of the same individual's quotes, revealing the classic face plant nature of the entire transaction are suspect ? I appreciate the input !
LOL
great link,thanks. Over promise, fail to deliver. Boots eyewitness testimony;
Anyway, why would (or how long can) a small company like JBI subsidize USS, selling fuel below mfg. cost ?
I re-added the missing & most important part of the first quote. Hope this helps ;'
Fascinating rebuttal. Thank you.
ok argue away this snake oil nonsense ;
Never mind the sky-pie promises constantly PRd then restated or just forgetten, the financial mismanagement of buying and selling (at loss) useless accessory companies, the SEC-attention-grabbing & penalized thus apparently crooked mis-statement of inflated assets, the whacked out compensation doled out to favorite sons, the long line of unhappy business partners constantly suing the shit out of JBI, and even the incremental mission creep of larger and ever more expensive complicated reactors using tighter spec & more costly feedstock, lets just consider some science.
The goal here is to thermally decompose solid state polymers to the correct vapor phase decomp products, that can be cracked and/or maybe reacted into the correct chain lengths to serve as a condensable (liquid) fuel.
To do this you have to achieve a correct temperature and atmosphere the break the chains, and then transfer the compounds from the solid state to the gas/vapor state. That transfer requires an interface, better known as a surface and requires a gas phase with a sub-equilibrium vapor pressure of the desire molecules order to not suppress evolution rates.
So currently we merrily flood the kilns with plastic bits plus gobs of oil, which absolutely KILLS the interface area but a magnitude of 4~8, probably much more (I wont bother with the calcs), I said MAGNITUDE - I did NOT say multiple. In other words sublimation/vaporization rate just went through the floor. That is THROUGHPUT; DOA.
Next we have to sweep the atmosphere of the goal molecules quickly enough to maintain said low partial P, which also entails great thermal losses that shift the thermal equilibrium away from necessary conditions. Since we have a slow turnover vessel ( not a fast fluidized bed) we lose again.
This whole thing reeks of a sophomoric attempt at a very sophisticated reactor. It might have done sort of what we wanted on a table top, but as it scaled to commercial sizes, different rate limiting factors came into play, which were not perceived by an inadequate engineering effort.
Maybe I can tone it down to a parable, the ferocious killer insect - at millimeter scale, that would be a helpless blob at meter scale ala the scary movies, for the simple reason that volume ( therefore mass) increases as a cubic while cross section area ( therefore structural strength) increases as a square. You run into inescapable factors as you scale.
Even if its true that sincere will power actually drove this operation to its current extent, and not just simple flim flam the Music Man hype, it was sadly not enough to overcome third year thermo & P chem considerations. Hell, even I can only see several of the problems, and not the solutions, cause this isn't my exact field. So if you want a textbook argument (and not that silly nawtec foofoo), go or ask around to PEng school. But I damn sure know a loser when I think about it.
This slow roll kiln / HTF / clean out channel just doesn't matter, its doomed by basic processing considerations.
The original silver bullet of a MagiCatalyst that was far more efficient than any others known; in a word; Bullshit. I don't believe that for a moment, and if I am wrong and such a substrate exists, since it was in the public domain long before being Juiced out of a forgotten archive, the moment it has any value, BAM it will for sale on alibaba and probably ebay.
Best luck to any one sadly holding this name for a turn around. I can barely even trade it because liquidity is so pathetic and consider myself very lucky to have flogged a few of the obvious and shrinking waves occurring over the last few quarters. For me, holding jbi over night usually ain't worth the lost sleep.
heat transfer fluid seems nuts; It takes up volume that plastic ... remember the original intended feedstock? was to occupy, and at much greater raw material expense. Its a fool's gold HT process as the heat-up rates & heat content demand, and thus net heat exchange, are NOT favorable compared to a gas phase. It reduces surface area available for outgassing vaporized components.
This is why energetic fluidized bed pyro is winning the war, compared to these sophomoric slow turnover kilns. My best guess is that the long dweel time is the root cause of the high naptha production rates. A little early professional engineering input would have prevented years of futile tinkerfarking expense and destroyed shareholder value ... that is IF commercial success was actually the goal here... a very big IF !
HTF is there to pump up the volume numbers for future PR and wont help process rates or economics at all. Why was in-process fluids simply recycled into the upstream feedstock ? To pump up the numbers for discussion purposes!
As far as your question, I would have to agree that different; ratios of polymer length & bonding / phase change temperatures / decomposition products / equilibrium vapor pressure feedstocks, will NOT have identical, or even within tolerance / compatible process temperatures. Thats why the "unwashed unsorted" thing did a face plant in favor of idealized costly & limited feedstocks.
FACTOID ALERT! 99.99% of the so called green SNAKEOIL SCAMS
end up crashing and burning in BK leaving all their investors embarrassed and flat broke.
Now that Cassandra is NYC's choice for a p2o vendor
Now that analysis shows a net loss (monetary and environmental) to rely on MagicMarker-to-oil scams.
Now that the litigants are lined up around the corner to carve the little flesh off JBII's bones before the Big Announcement means y'all outtaluck.
Now that company touts are pitching a machine sale (a) nobody sane wants one, (b) if by some weird chance they ever do, there goes the golden goose!
My comments are my opinions. My DD is my own. I am not paid to post. Do not take my comments as investment advice. Make your own decisions.
And for gods sake Get. Out. Now
Does FDA want REDUCE-IT completed?Anchor will be approved.
Summer Street will cover their short long before they say anything positive.
well, then,,, link?
Dont makeme dragout allthe crap summerstreet has said.
Do your own DD. SS = Joke house and everyone knows it.
Thats why its so fun to see they are the down beat ones.
True, well almost, just a significant fine to Co & personnel and betch slap to stay out of the CEO / BOD seat.
How can this even be argued in this well documented point in time?
We still have one potential prosecution going to date , too, yes ?
lol- hiding ; yes, intellectual property agreements and proprietary information.
Go look up that section to that document - its a technology agreement with Cal Tech , I believe , though it could be another higher ed institution.
Its already riddled with redactions as are the surround exhibits, for clear business reasons.
looks like those happy panic liquidation days are here again. Any news secret or otherwise what todays slaughter is all about ?
by all other measures thats A SALE
Aegis on recent news
Generic Lovaza May Still Be Years Away. Yesterday, it was announced that Teva Pharmaceutical Industries (TEVA/NYSE, Not Rated) and Par Pharmaceutical Co. (Private) had won an appeal against Pronova BioPharma in the U.S. Court of Appeals in their ongoing battle to obtain the right to launch a generic version of Pronova's Lovaza (omega-3-acid ethyl esters) in the U.S. We believe that the negative reaction to this news by Amarin investors was both ill-considered and unwarranted. In anticipation of approval of Vascepa™ in mixed dyslipidemia in December 2013, we reiterate our Buy rating and 12-month price target of $30.00 on Amarin shares.
Teva / Par Victory Does Not Mean Curtains For Amarin. We believe that the Lovaza patent news yesterday is of minimal relevance for several reasons. First, this appeals court decision does not automatically allow Teva and Par to begin marketing a Lovaza generic in the U.S. The case was yesterday remanded back to the lower district court, which in 2012 ruled in favor of Pronova. Second, we believe that Teva may have problems accessing sufficient fish oil supply to even make a generic version of Lovaza at commercial scale. Third, even if Lovaza generics eventually appear in the U.S., we believe that Amarin's Vascepa will remain viable as a commercial franchise because we remain optimistic that the drug will be approved near-term for use in mixed dyslipidemia. As we have stated repeatedly in the past, Lovaza cannot secure a label in mixed dyslipidemia as it elevates LDL-cholesterol. Thus, if Vascepa receives a mixed dyslipidemia label it should effectively become immune to cheaper competitors like Lovaza generics.
No Free Ride For Generics. We would remind investors that overturning the Lovaza patent estate is not a particularly noteworthy achievement. One of the Pronova patents initially challenged by Teva and Par expired in March of this year, while the other (the '667 patent) expires in April 2017. Investors would be well-advised to remember that even if generic filers win on the litigation front, they still have to obtain FDA approval for their copycat drugs. Thus far, the FDA has yet to approve a single Lovaza generic. Again, even if generics of Lovaza were to appear, they would not have a label in mixed dyslipidemia and would not be usable in that indication as reimbursement agencies would not be able to pay for them.
FDA Advisory Panel Does Not Present Cause For Concern. A panel vote on the approvability of Vascepa in mixed dyslipidemia is taking place on October 16, 2013. There is substantial cardiac outcomes-based evidence, most notably from the well-powered GISSI-Prevenzione and JELIS studies, that prescription-grade omega-3 fatty acids like Vascepa improve cardiovascular outcomes and reduce deaths in mixed dyslipidemia patients.
article basically shit but some comments brilliant;
read http://seekingalpha.com/article/1670072-jbis-plastic2oil-goes-national
particularly profound;
North, you seem to be on top of this; one thing I'd like to get better clarity on;
So a company that invented product or use of substance, enough to obtain the original patent, lets a little out the door to a physician to test, and that somehow breaks their own line inventorship / novelty ?
The court seemed to decide they stole it from themselves and after the fact ... very counterintuitive / counter productive.
A technicality decision indeed. Will this decision stand review ?
thanks
correct as usual hornettt!
How did this SNAKE OIL operation only manage 5 possible genuine trades today... and why were ALL of the bid bangers ?
One of the great selling points of Vascepa is that a generic lovaza wont have much price differential from branded. There is little in the way of manufacturing savings possible.
Next, the major manufacturer of lovaza also has contracts to supply vascepa API. Let me guess, will they concentrate on the higher or lower margin product ?
The last gem is Best in Class status .... for a whole new larger class!
The Lovaza is dead/ Long live Vascepa !
Why ?!? Must have been a ruse to let me make x4x now 5 profitable trades today ?
How is volume a bad thing ?
Getting stuck in a stock with no trades is a baaaaaad thing, not swings.
The panic put a bunch of of new$ at my feet today.
HEY LOOKIE ! 3 whole real trades today and each one a perfect sell chance for the untelligent investor to add to their position in what was once JBII.
I probably understand how a buy a 40 yesterday made a good sale today at 38
even if I heard it 1000 times.
Were those Fraudivvy shares sold today , or just another squid bait hitting the fan ?
does TEVA even have a ground force ? I thought that was one of their problems with ramping name drugs
LOL 30,000 MORE Shares of this pig dumped today. Beautiful thing when the only trade is a rout. Wonder what whale is have a party this w/e on the proceeds ?
Do I correctly understand relevant patent law? A public use of the subject matter of the claims of a patent in suit, more than 1 year prior to the application date for patent that issues containing those claims, invalidates those claims under 35 U.S.C. 102(b), the provision of patent law relied on by the Fed. Cir. Note that the court relied on the "old" law in effect since 1952.
I understand relevant provisions of patent law. A public use of the subject matter of the claims of a patent in suit, more than 1 year prior to the application date for patent that issues containing those claims, invalidates those claims under 35 U.S.C. 102(b), the provision of patent law relied on by the Fed. Cir. Note that the court relied on the "old" law in effect since 1952.
LOL Bullshit.
You forgot a post-to-float ratio nonpareil.
I believe there are now more promoters than shareholders of record.
BANG here comes the rain again. Tiny pump Massive Dump.
down another 5%. I feel a zip point deuce handle coming on
Yes do please go on record as to how Amarin insiders concealed share sales.
It would be fascinating even if going back nearly a year to find any examples of legal sales.
Also please discuss methods how to conceal insider share sales.
We are very open minded here so feel free to draw on other investments to illustrate exactly how key insiders manipulate their generous holdings to evade disclosure. Thanks in advance!
Heres what we know already but if its fulfilling to dredge back;
http://openinsider.com/search?q=amrn